L

Labgenomics Co Ltd
KOSDAQ:084650

Watchlist Manager
Labgenomics Co Ltd
KOSDAQ:084650
Watchlist
Price: 2 455 KRW 0.2% Market Closed
Market Cap: 182.3B KRW
Have any thoughts about
Labgenomics Co Ltd?
Write Note
Labgenomics Co Ltd
/
Cash Flow Statement
/
Net Income

Labgenomics Co Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Labgenomics Co Ltd
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
L
Labgenomics Co Ltd
KOSDAQ:084650
Net Income
-₩22.7B
CAGR 3-Years
N/A
CAGR 5-Years
-66%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Net Income
₩183.8B
CAGR 3-Years
-31%
CAGR 5-Years
-5%
CAGR 10-Years
6%
SK Bioscience Co Ltd
KRX:302440
Net Income
₩22.3B
CAGR 3-Years
-12%
CAGR 5-Years
20%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Net Income
₩119.4B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Net Income
₩88.1B
CAGR 3-Years
22%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Net Income
-₩5.1B
CAGR 3-Years
41%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

Labgenomics Co Ltd
Glance View

Market Cap
182.3B KRW
Industry
Biotechnology

LabGenomics Co., Ltd. engages in the provision of vitro diagnostic products and services. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2013-07-01. The firm mainly provides IVD services, including general diagnostic check services, molecular diagnostic check services, and research and development services. The Company’s IVD products include deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) kits and others. The company also provides examination for breast cancer and colorectal cancer, biosensor for point of care testing (POCT) and others. The company also provides healthy food.

Intrinsic Value
2 727.2 KRW
Undervaluation 10%
Intrinsic Value
Price
L
What is Intrinsic Value?

See Also

What is Labgenomics Co Ltd's Net Income?
Net Income
-22.7B KRW

Based on the financial report for Sep 30, 2024, Labgenomics Co Ltd's Net Income amounts to -22.7B KRW.

What is Labgenomics Co Ltd's Net Income growth rate?
Net Income CAGR 5Y
-66%

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.